BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21600917)

  • 21. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter.
    Chai YL; Cui J; Shao N; Shyam E; Reddy P; Rao VN
    Oncogene; 1999 Jan; 18(1):263-8. PubMed ID: 9926942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Boundaries and physical characterization of a new domain shared between mammalian 53BP1 and yeast Rad9 checkpoint proteins.
    Alpha-Bazin B; Lorphelin A; Nozerand N; Charier G; Marchetti C; Bérenguer F; Couprie J; Gilquin B; Zinn-Justin S; Quéméneur E
    Protein Sci; 2005 Jul; 14(7):1827-39. PubMed ID: 15987907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRCT domain interactions in the heterodimeric DNA repair protein XRCC1-DNA ligase III.
    Dulic A; Bates PA; Zhang X; Martin SR; Freemont PS; Lindahl T; Barnes DE
    Biochemistry; 2001 May; 40(20):5906-13. PubMed ID: 11352725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.
    Rodriguez M; Yu X; Chen J; Songyang Z
    J Biol Chem; 2003 Dec; 278(52):52914-8. PubMed ID: 14578343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function.
    Tembe V; Martino-Echarri E; Marzec KA; Mok MT; Brodie KM; Mills K; Lei Y; DeFazio A; Rizos H; Kettle E; Boadle R; Henderson BR
    Cell Signal; 2015 Sep; 27(9):1763-71. PubMed ID: 26022179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein.
    Ayi TC; Tsan JT; Hwang LY; Bowcock AM; Baer R
    Oncogene; 1998 Oct; 17(16):2143-8. PubMed ID: 9798686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1.
    Williams RS; Green R; Glover JN
    Nat Struct Biol; 2001 Oct; 8(10):838-42. PubMed ID: 11573086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The BRCA1 C-terminal domain: structure and function.
    Huyton T; Bates PA; Zhang X; Sternberg MJ; Freemont PS
    Mutat Res; 2000 Aug; 460(3-4):319-32. PubMed ID: 10946236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BRCT repeats as phosphopeptide-binding modules involved in protein targeting.
    Manke IA; Lowery DM; Nguyen A; Yaffe MB
    Science; 2003 Oct; 302(5645):636-9. PubMed ID: 14576432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair.
    Callebaut I; Mornon JP
    FEBS Lett; 1997 Jan; 400(1):25-30. PubMed ID: 9000507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling.
    Shiozaki EN; Gu L; Yan N; Shi Y
    Mol Cell; 2004 May; 14(3):405-12. PubMed ID: 15125843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo.
    Quaresima B; Faniello MC; Baudi F; Crugliano T; Di Sanzo M; Cuda G; Costanzo F; Venuta S
    Oncol Rep; 2006 Oct; 16(4):811-5. PubMed ID: 16969499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure of an XRCC1 BRCT domain: a new protein-protein interaction module.
    Zhang X; Moréra S; Bates PA; Whitehead PC; Coffer AI; Hainbucher K; Nash RA; Sternberg MJ; Lindahl T; Freemont PS
    EMBO J; 1998 Nov; 17(21):6404-11. PubMed ID: 9799248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic analysis of interaction of BRCA1 tandem breast cancer c-terminal domains with phosphorylated peptides reveals two binding conformations.
    Nominé Y; Botuyan MV; Bajzer Z; Owen WG; Caride AJ; Wasielewski E; Mer G
    Biochemistry; 2008 Sep; 47(37):9866-79. PubMed ID: 18717574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer predisposing mutations in BRCT domains.
    di Masi A; Gullotta F; Cappadonna V; Leboffe L; Ascenzi P
    IUBMB Life; 2011 Jul; 63(7):503-12. PubMed ID: 21698754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.
    Dizin E; Irminger-Finger I
    Int J Biochem Cell Biol; 2010 May; 42(5):693-700. PubMed ID: 20060929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRCT domains: easy as one, two, three.
    Leung CC; Glover JN
    Cell Cycle; 2011 Aug; 10(15):2461-70. PubMed ID: 21734457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
    Williams RS; Lee MS; Hau DD; Glover JN
    Nat Struct Mol Biol; 2004 Jun; 11(6):519-25. PubMed ID: 15133503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural basis for the BRCA1 BRCT interaction with the proteins ATRIP and BAAT1.
    Liu X; Ladias JA
    Biochemistry; 2013 Oct; 52(43):7618-27. PubMed ID: 24073851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a RING protein that can interact in vivo with the BRCA1 gene product.
    Wu LC; Wang ZW; Tsan JT; Spillman MA; Phung A; Xu XL; Yang MC; Hwang LY; Bowcock AM; Baer R
    Nat Genet; 1996 Dec; 14(4):430-40. PubMed ID: 8944023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.